.png)
.png)
President & Chief Operating Officer
Nabriva Therapeutics
Disclosure(s): Nabriva Therapeutics: Board Member, Employee, Inventor, Stocks/Bonds, Stocks/Bonds
Steven Gelone joined Nabriva Therapeutics in December 2014. Over the past 20 years, Steve has been involved in all stages of drug development and commercialization. He has served as Head of Clinical Research and Development at Spark Therapeutics, as well as Vice President of Development at ViroPharma Inc., (now Shire). Previous roles include leadership positions with GSK, Vicuron Pharmaceuticals, and Temple University Schools of Pharmacy and Medicine. He has a Bachelor of Sciences and Doctorate in Pharmacy degree from Temple University in Philadelphia.